TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

5.80$ -4.6% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns Neuraxis, Inc. (NRXS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.4% of the shares are freely tradable; institutional investors hold 24.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 24.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 19.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 66.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 13Mio.

Largest Shareholders

No ownership data is available for this stock yet.

Insider holdings

Insider holdings NRXS
Person Role Shares Value As of Type
Aharon Gil Director 628,181 3,643,450 $ Jul 29, 2026 both
Carrico Brian Allen Chief Executive Officer 227,604 1,320,103 $ Oct 8, 2026 direct
Carrico Thomas Joeseph CRO, CCO, CPO 199,673 1,158,103 $ Oct 8, 2026 direct
Miranda Adrian CMO, SVP Science & Tech 199,106 1,154,815 $ Aug 24, 2026 direct
Watkins Bradley Mitchell Director 72,408 419,966 $ Aug 13, 2026 direct
Keyser Jane Elizabeth Director 72,408 419,966 $ Aug 13, 2026 direct
Ferge Kristin A Director 67,072 389,018 $ Aug 13, 2026 direct
Henrichs Timothy Robert Chief Financial Officer 9,530 55,274 $ Oct 8, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 8, 2026 Carrico Brian Allen Chief Executive Officer Buy 268 4.84 1,297
Oct 8, 2026 Carrico Thomas Joeseph CRO, CCO, CPO Buy 328 4.84 1,588
Oct 8, 2026 Henrichs Timothy Robert Chief Financial Officer Buy 1,937 4.84 9,375
Aug 24, 2026 Miranda Adrian CMO, SVP Science & Tech Other 199,106 – –
Aug 24, 2026 Carrico Thomas Joeseph CRO, CCO, CPO Other 193,678 – –
Aug 24, 2026 Carrico Brian Allen Chief Executive Officer Other 199,188 – –
Aug 13, 2026 Watkins Bradley Mitchell Director Other 26,073 6.28 163,738
Aug 13, 2026 Keyser Jane Elizabeth Director Other 26,073 6.28 163,738
Aug 13, 2026 Ferge Kristin A Director Other 31,134 6.28 195,522
Aug 13, 2026 Aharon Gil Director Other 43,930 6.28 275,880
Jul 29, 2026 Aharon Gil Director Other 40,068 – –
Jul 29, 2026 Aharon Gil Director Other 2,226 – –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?